Mytus Injection 100 IU/ml contains Insulin Glargine, a long-acting basal insulin analogue used for the management of diabetes mellitus. Insulin Glargine provides consistent, peakless insulin coverage for up to 24 hours, helping maintain stable fasting blood glucose levels. It is particularly beneficial for patients with type 1 or type 2 diabetes who require basal insulin support as part of a comprehensive glycemic management plan.

Insulin Glargine is a recombinant DNA-derived human insulin analogue that is formulated to release slowly and steadily into the bloodstream. Unlike short-acting insulin, which has a rapid peak and requires multiple daily injections, Insulin Glargine mimics the body’s natural basal insulin secretion, reducing fluctuations in blood glucose and minimizing the risk of hypoglycemia. Mytus Injection 100 IU/ml is ideal for once-daily administration and can be combined with rapid-acting insulin or oral antidiabetic medications for optimal glycemic control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Mytus Injection 100 IU/ml is indicated for:

• Type 1 diabetes mellitus – as part of a basal-bolus regimen, in combination with rapid-acting insulin for mealtime coverage

• Type 2 diabetes mellitus – when oral antidiabetic medications alone are insufficient to achieve glycemic targets

• Maintenance of fasting blood glucose levels in patients requiring basal insulin

• Management of hyperglycemia in adults, adolescents, and children as prescribed by a healthcare professional

This long-acting insulin provides reliable, consistent coverage to help prevent complications associated with chronic hyperglycemia.

Key Benefits

• Provides up to 24-hour, peakless insulin coverage

• Reduces the risk of nocturnal and fasting hypoglycemia compared to intermediate-acting insulins

• Supports stable glycemic control, improving overall diabetes management

• Compatible with basal-bolus therapy, insulin pumps, or oral antidiabetic drugs

• Once-daily injection improves adherence and convenience for patients

Mytus Injection 100 IU/ml helps patients maintain steady blood glucose levels, reducing the long-term risk of diabetes-related complications such as cardiovascular disease, neuropathy, and retinopathy.

Dosage and Administration

• The dose must be individualized based on blood glucose monitoring, body weight, diet, and physical activity.

• Administer subcutaneously once daily, preferably at the same time each day, in the abdomen, thigh, or upper arm.

• Rotate injection sites to avoid lipodystrophy and ensure consistent absorption.

• Can be combined with short-acting or rapid-acting insulin to cover mealtime glucose spikes.

• Regular monitoring of blood glucose is essential to adjust the dose and prevent hypo- or hyperglycemia.

Precautions

• Monitor for hypoglycemia, which can present with sweating, shakiness, dizziness, or palpitations.

• Adjust the dose during illness, stress, changes in diet, or physical activity.

• Inform your physician about all medications to prevent interactions affecting blood sugar.

• Use under medical supervision in pregnancy or lactation.

• Always have a source of fast-acting sugar available for emergency management of low blood glucose.

Possible Side Effects

Mytus Injection 100 IU/ml is generally well tolerated. Potential side effects include:

• Hypoglycemia (low blood sugar)

• Injection site reactions, such as redness, swelling, or mild pain

• Weight gain with prolonged use

• Rare allergic reactions, including rash, itching, or anaphylaxis

Careful monitoring and proper injection technique minimize adverse effects.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store unopened vials in a refrigerator at 2–8°C. Do not freeze.

• Protect from light and moisture.

• After opening, it may be kept at room temperature (below 30°C) for the period advised by the physician.

• Keep out of reach of children.

Mytus Injection 100 IU/ml (Insulin Glargine) provides reliable, long-acting basal insulin coverage, helping patients achieve stable fasting glucose control and supporting effective management of type 1 and type 2 diabetes.